Randomized phase ll study of mFOLFOX6 + bevacizumab or mFOLFOX6+cetuximab in liver only metastasis from KRAS wild type colorectal cancer
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Bevacizumab (Primary) ; Cetuximab; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- Acronyms ATOM
- 01 Aug 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 03 Apr 2017 Planned End Date changed from 6 May 2017 to 31 Mar 2017.